Health Catalyst officer plans sale of 17,973 shares

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) has a Form 144 filing indicating that officer Jason Alger plans to sell up to 17,973 shares of common stock of Health Catalyst through Morgan Stanley Smith Barney LLC under Rule 144, with an intended sale date of September 1, 2026.

The shares are described as Restricted Stock acquired as compensation75,256,381 as of September 1, 2026; this is a baseline figure, not the amount being sold. Over the prior three months, Alger reported selling 18,804 restricted shares for an aggregate value of $25,765.24.

Key Figures

Shares to be sold: 17,973 shares of common stock Aggregate market value of planned sale: $30,618.80 Shares outstanding: 75,256,381 shares +2 more

5 metrics

Shares to be sold 17,973 shares of common stock Planned Rule 144 sale by Jason Alger on or after September 1, 2026

Aggregate market value of planned sale $30,618.80 Value for 17,973 shares of Health Catalyst common stock

Shares outstanding 75,256,381 shares Health Catalyst common shares outstanding as of September 1, 2026

Shares sold in past 3 months 18,804 shares Restricted Stock sold by Jason Alger on June 1, 2026

Aggregate value of past 3 months' sales $25,765.24 Value of 18,804 restricted shares sold June 1, 2026

Key Terms

Rule 144, Restricted Stock, aggregate market value, securities to be sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 09/01/2026 | Restricted Stock | Health Catalyst, Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 17973 | 30618.8 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

securities to be sold financial

"Name of Person for Whose Account the Securities are To Be Sold"

FAQ

What does the Form 144 filing for HCAT disclose about Jason Alger's planned stock sale?

The filing states that officer Jason Alger intends to sell up to 17,973 shares of Health Catalyst common stock as Restricted Stock compensation under Rule 144, with an intended sale date of September 1, 2026 through Morgan Stanley Smith Barney LLC.

How many Health Catalyst (HCAT) shares are covered by Jason Alger’s current Form 144?

The Form 144 covers up to 17,973 shares of Health Catalyst common stock. These are described as Restricted Stock that Alger intends to sell pursuant to Rule 144 on or after September 1, 2026.

What was the aggregate market value of the HCAT shares in Jason Alger’s planned Rule 144 sale?

The filing lists an aggregate market value of approximately $30,618.80 for the 17,973 shares of Health Catalyst common stock covered by the planned Rule 144 sale.

How many Health Catalyst (HCAT) shares were outstanding as of the Form 144 reference date?

The Form 144 reports that 75,256,381 shares of Health Catalyst common stock were outstanding as of September 1, 2026. This is a total share count, not the number being sold.

What HCAT share sales has Jason Alger reported in the past three months?

Over the past three months, Jason Alger reported selling 18,804 shares of Health Catalyst Restricted Stock on June 1, 2026 for an aggregate value of $25,765.24, according to the Form 144 disclosure.

Through which broker does the HCAT Form 144 indicate Jason Alger will sell his shares?

The Form 144 indicates that the planned sale of 17,973 shares of Health Catalyst common stock will be executed through Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 38th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 05:47 PM Accepted by SEC EDGAR 09/01/2026 - 05:47 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839111
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Jason Alger
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	17973	30618.8	75256381	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock	Health Catalyst, Inc.			17973	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jason Alger c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/01/2026	18804	25765.24

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jason Alger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)